The Diabetes Centre is committed to be recognized as a global leader improving the lives of people with diabetes
TDC Research & Development Centre
The Diabetes Centre is committed to be recognized as a global leader improving the lives of people with diabetes, irrespective of their ability to pay, through medical care, education, research, innovation and advocacy for cure and prevention of the disease.
With an aim to develop a thriving place where knowledge is generated, hypothesis are developed and proved; TDC has established Research and Development Centre. The Research Centre will facilitate and co-ordinate research activities for continual improvement of the healthcare management system. TDC is determined to reducing the burden of diabetes and its related complexities by providing continuous medical care through multifactorial risk-reduction strategies including glycemic control, ongoing patient self-management education, and support in preventing diabetes patients from critical and acute complications and reducing the risk of long-term complications.
A Clinical Trial Site (CTS) at TDC for Phase III & IV has been approved by Drug Regulatory authority of Pakistan (DRAP) in 2021. The purpose of this clinical trial site is to explore the new interventions and clinical guidelines to prevent the diabetes and its related complications.
TDC R&D Centre is sure to set the highest standards of healthcare delivery in Pakistan.